Filing Flows › Nutra Pharma (NPHC) › Q1 2026
Nutra Pharma (NPHC) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 29, 2026
Nutra Pharma (NPHC) reported revenue of $27K for the first quarter 2026 (Q1 2026), -63% from a year earlier and -6% from the quarter before.
Nutra Pharma, Q1 2026: revenue $27K (-63% year over year), net loss $460K, operating cash flow −$328K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27K | -6% | -63% |
| Operating profit | −$379K | — | — |
| Net earnings | −$460K | — | — |
| Operating cash flow | −$328K | — | — |
What changed
Revenue was $27K in Q1 2026, down 63% year over year and down 6% from the previous quarter.
Gross margin was 69.6%, down 10.3 points from Q1 2025. Operating costs exceeded revenue by $379K, an operating margin of -1391.9%. Operating expenses fell 3% while revenue fell 63%. The quarter ended with a net loss of $460K, narrower than the previous quarter's $489K loss.
Operating cash flow was −$328K. Non-cash charges added back $3K of depreciation and $11K of share-based compensation. Working capital and other items added $118K.
Questions
What was Nutra Pharma's revenue in the first quarter 2026?
Nutra Pharma (NPHC) reported revenue of $27K for the first quarter 2026 (Q1 2026), -63% from a year earlier and -6% from the quarter before.
Source: Nutra Pharma 10-Q on SEC EDGAR.